• Activity INFORMATION

  Overview

  Polypharmacy (taking 5 or more medications regularly) is growing in prevalence. This may result in an increased risk of drug interactions and adverse effects. The stakes are particularly high in patients living with a serious illness. Participants in this session will learn about how to select and discontinue medications that are specific to the patient's goals of care, particularly in light of their serious illness.
  

  Handouts

  • Slide Document :   24078H01_2pp.pdf Download

  • Slide Document :   24078H01_6pp.pdf Download

  Financial Support By

  PharmCon

• Learning OBJECTIVES

  Pharmacist

  Describe best practices in deprescribing in metabolic syndrome

  Describe a systematic approach to deprescribing in the elderly and those with advanced illness

  Describe best practices in deprescribing in Alzheimer’s disease

  Nurse

  Describe a systematic approach to deprescribing in the elderly and those with advanced illness

  Describe best practices in deprescribing in Alzheimer’s disease

  Describe best practices in deprescribing in metabolic syndrome

• Activity ACCREDITATION

  Activity Type

  Knowledge

  CE Broker

  20-1261257

  Universal Activity Number

  Pharmacist 0798-0000-24-078-H01-P
  Nurse 0798-0000-24-078-H01-N
  

  PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

  PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

  In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

• Activity INSTRUCTION

  Faculty

  Mary Lynn  McPherson, PharmD, PhD, BCPS, FAAHPM Professor and Executive Director, Advanced Post-Graduate Education in Palliative Care, University of Maryland School of Pharmacy

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).